Thank you, Amanda, and good morning, everyone. On behalf of all of the employees at Olaplex, I'd like to say that we are thrilled to have Amanda leading this team. Since joining the company less than three months ago, Amanda has made a significant impact, and we are excited about the direction that she's taking the business. To start, I'll say that our Q4 2023 results were in line with our expectations which landed on the upper end of our latest guidance on all metrics. We believe that these results were another positive step forward in showing a stabilized demand trend. Similar to last quarter, I'd like to provide an update on several metrics that we are tracking to measure progress on the demand trend. First, sell-through in Q4 2023 at key accounts was down 27% versus last year, comparable with Q3 2023 also down 27% versus last year, and full year 2023 down 28% versus last year. Notably, our Q4 net sales or sell-in decline of 14.5% versus last year was better than the sell-through trend as we are beginning to lap inventory rebalancing from certain Pro and specialty retail customers from a year ago. As we shared last quarter, we believe that the month’s on-hand inventory position at our major accounts on our core items remain in a healthy position, and there is no inventory building in our channels. Second, aggregated sell-out sales dollars at key accounts on an absolute dollar basis grew sequentially in Q4 2023 versus Q3 2023 by 21%. This was in line with our expectation given what we've seen historically during the holiday season, including the sell-through of our holiday kits. Next, performance from olaplex.com remain strong, growing year-over-year for the third consecutive quarter and up double digits in Q4 compared to the fourth quarter of 2022. And as we believe this business continues to build off of the momentum generated by our increased marketing investments. And finally, consistent with previous quarters, our brand health metrics among prestige hair care consumers remain strong and industry-leading. According to our external brand tracker, Olaplex is ranked number one or tied for number one for 13 of the top 17 premium hair care equities, up from 10 in Q3 2023, which include Best for my Hair, highest quality products and brand I am excited to talk about. Now turning to our financial results for the fourth quarter. Net sales declined 14.5% year-over-year to $111.7 million, in line with our expectations. By channel, as compared to the fourth quarter of 2022, our professional channel sales declined 22.7% to $42.5 million. The direct-to-consumer channel decreased 2.8% to $42 million; and specialty retail sales were down 16.3% to $27.3 million. By geography, in the fourth quarter, the U.S. declined 27.9% compared to a year ago and international was flat year-over-year. Adjusted gross profit margin was 70.6%, down 190 basis points from 72.5% in the fourth quarter of 2022. Approximately 320 basis points of this decline is related to higher inventory obsolescence reserves, 140 basis points from promotional allowance and 50 basis points from inflation on product costs. These more than offset the 300 basis point benefit, primarily from lower warehouse and distribution costs and 140 basis points from more favorable product mix. Adjusted SG&A grew 54.4% to $44.5 million from $28.8 million in the fourth quarter of 2022. The $16 million increase in adjusted SG&A from prior year is primarily the result of an $11 million increase in sales and marketing expense as well as an increase in payroll attributable to workforce expansion and other related expenses. Adjusted EBITDA declined 46.8% to $36 million versus $67.6 million in the fourth quarter of 2022. Adjusted EBITDA margin was 32.2% compared to 51.7% a year ago. Adjusted net income decreased 53.9% year-over-year, $22.3 million or $0.03 per diluted share from $48.3 million or $0.07 per diluted share in the fourth quarter of 2022. Turning to our balance sheet. Inventory at the end of the fourth quarter was $95.9 million down from $112.8 million at the end of the third quarter as we continue to make progress against our goal to lower our inventory to target levels of months on hand. Turning to cash flow. During fiscal year 2023, we generated $177.5 million in cash from operations. We remain a healthy cash flow generating business due to our asset-light model high profitability and continuous improvement in our working capital position. We ended the year with $466.4 million in cash and equivalents up $36.8 million from the end of Q3 and an increase of $143.6 million from the end of 2022. This cash is generating interest income at an annual rate above 5%. Long-term debt, net of current portion and deferred fees was $649 million. Now turning to our financial outlook. As disclosed in our earnings release issued this morning, for fiscal year 2024, we expect Net sales in the range of $435 million to $463 million, adjusted EBITDA in the range of $143 million to $159 million, and adjusted net income in the range of $87 million to $100 million. Now let me walk you through our assumptions for fiscal year 2024. Beginning with net sales. For fiscal year 2024, our plan assumes generally that the absolute dollar sell-through trend that we experienced in the second half of 2023, adjusted for seasonality represents our normalized base level of sell-through for the year. From there, we build in all expected volume drivers on a product and account level basis. I'll now elaborate on three of those major volume drivers. First, we anticipate incremental sales contribution from new product launches this year, but expect the contribution from new products in 2024 to be lower than in 2023 given the timing of key launches starting later this year. We are continuing with our recent cadence of two to four launches per year. Second, on the distribution front, we're taking several actions that are focused on our long-term success but have a negative short-term impact. We've decided to constrain opening up new accounts in 2024 and as we focus on improving awareness and penetration in our current key customers. In addition, we plan to rationalize certain distributors and accounts that do not build brand equity either due to off-strategy pricing for sub distribution into unauthorized resellers. We are using various methods, including our track and trace technology, third-party experts, and other anti-diversion and anti-counterfeiting measures to specifically target the distributor rationalization. We've already made good progress here in the second half of 2023, so we're planning to continue those efforts. Lastly, we expect a year-over-year net sales growth tailwind as we lap the effects of customer inventory rebalancing in 2023 and which had the impact of depressing our 2023 net sales base. Geographically, we expect the U.S. to benefit the most in 2024 from lapping customer inventory rebalancing in 2023. In our international business, we expect continued growth in our emerging growth regions of APAC and Latin America, where we expanded our distribution in 2023. This will include our recent small-scale launch into Mainland China which we're able to execute while still adhering to our commitment to be a cruelty-free brand. We also note that the aforementioned distributor rationalization is expected to be a short-term negative volume impact, particularly in Europe. On a channel basis, we expect year-over-year net sales performance to be balanced and similar across channels for fiscal year 2024. Now let me provide additional commentary on how we expect net sales trends to develop from a phasing perspective in 2024. In short, we expect momentum to build over the course of the year as our investments and initiatives land in the market. First, we have a more difficult underlying sell-through comparator in the first half of the year, particularly in Q1 and then we do in the second half of 2024. Second, we will be lapping the pipeline impact from our Q1 2023 new product launches and expect a more significant positive impact from our new product launches in second half 2024, given the timing of those launches. Lastly, we expect the year-over-year tailwind of lapping customer inventory rebalancing in the prior year to benefit us primarily in the first half of this year. This will be partially offset, however, with the aforementioned distributor rationalization, which is phased across the year. With all of this in mind, specifically for Q1, we expect net sales in the range of $92 million to $97 million, when looking at year-over-year channel performance in Q1, we expect our DTC business will outperform relative to the professional and specialty retail channels. Moving down the P&L. For the full year 2024, we assume adjusted gross margin in the range of 72.5% to 73.1% representing expansion of 110 to 170 basis points. This is the result of lapping high levels of inventory obsolescence from last year and the expectation of normalized promotional levels this year as we lap promotions to move excess customer inventory last year. In addition, we expect to benefit from a dedicated internal cost savings program which we expect will more than offset some inflationary pressures in product costs. Furthermore, we expect full year 2024 adjusted SG&A expenses in the range of $172 million to $179 million, an increase of $19 million to $26 million versus 2023. Roughly half of that increase is expected in organization costs, primarily from annualizing the cost of head count additions made during 2023 and from the accrual for a normalized bonus payout in 2024. We believe that this puts our organization costs as a percentage of sales at a level that we expect to maintain for the foreseeable future. The other half of the increase is expected in our sales and marketing expenses as we invest at levels we believe are required to return to long-term growth. Specifically, we expect full year non-payroll related marketing and advertising expenses to be in the range of $66 million to $70 million, an increase from $60.5 million in 2023. Taken all together, we anticipate continuing to achieve top-tier industry profitability with adjusted EBITDA margin in the range of 32.8% to 34.3%. We assume net interest expense to be approximately $32 million to $34 million and an adjusted effective tax rate of approximately 19.5% to 20.5% for the year. In conclusion, we are confident in the progress that we are making to support the long-term health and growth of the Olaplex business. We expect momentum to continue to build as we execute against our strategy and the priorities that Amanda has outlined for the business in 2024. This concludes our prepared remarks. We will now turn the call back over to the operator for questions. Operator?